CAI
Caris Life Sciences, Inc.
32.30$
+2.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 6.3% | 6.2% | 5.9% | 13.4% | 7.9% | 4.4% | 27.8% | 31.6% | 34.3% | 49.6% | 53.3% | 51.4% | 50.6% | 51.9% | 37.4% | 69.0% | 70.8% | 56.6% | 33.6% | |
| 100.0% | 100.0% | 100.0% | 93.7% | 93.8% | 94.1% | 86.6% | 92.1% | 95.6% | 72.2% | 68.4% | 65.7% | 50.4% | 46.7% | 48.6% | 49.4% | 48.1% | 62.6% | 31.0% | 29.2% | 43.4% | 66.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 39.2% | 38.2% | 27.6% | 5.6% | |
| – | – | – | – | – | – | – | – | – | – | 9.1% | – | 11.1% | 12.1% | 12.3% | 11.6% | 12.7% | 9.3% | 60.4% | 49.6% | 42.1% | 27.7% | |
| 92.3% | 65.5% | 60.8% | 29.0% | 32.2% | 40.9% | 51.7% | 44.6% | 44.5% | 20.1% | 20.7% | 23.1% | 23.2% | 24.3% | 18.3% | 15.0% | 16.9% | 15.3% | 153.1% | 133.6% | 105.7% | 60.8% | |
| 7.7% | 34.5% | 39.2% | 64.7% | 61.6% | 53.3% | 35.0% | 47.5% | 51.1% | 52.1% | 47.7% | 42.6% | 27.3% | 22.4% | 30.3% | 34.4% | 31.3% | 47.3% | -122.2% | -104.4% | -62.4% | 5.6% | |
| 15.4% | 11.5% | 12.7% | 20.0% | 16.0% | 11.2% | 6.6% | 6.8% | 12.8% | 16.6% | 17.0% | 15.5% | 14.4% | 14.5% | 15.2% | 18.1% | 19.0% | 20.9% | 10.3% | 10.3% | 12.1% | 7.0% | |
| -7.6% | 23.1% | 26.6% | 44.9% | 46.8% | -18.5% | 26.8% | 40.8% | 49.2% | 42.6% | 33.7% | 29.7% | 12.5% | 3.4% | 16.4% | 18.9% | 13.3% | 10.0% | -124.1% | -111.5% | -68.4% | -8.4% | |
| -2.1% | 9.2% | 10.4% | 16.8% | 17.1% | 13.9% | 6.0% | 4.6% | 8.8% | 5.6% | 3.3% | 3.2% | 1.7% | 1.3% | -4.3% | 0.7% | 1.0% | 0.6% | – | – | – | 57.9% | |
| -5.5% | 13.8% | 16.2% | 28.1% | 29.6% | -32.4% | 20.8% | 36.4% | 39.9% | 36.5% | 30.1% | 26.5% | 10.7% | 2.0% | 20.7% | 18.2% | 7.4% | 9.4% | -124.1% | -111.5% | -68.4% | -66.2% | |
| 39.7% | 57.8% | 63.4% | 80.3% | 79.4% | 13.8% | 62.4% | 76.5% | 89.7% | 87.3% | 82.6% | 79.8% | 72.6% | 54.1% | 64.2% | 65.6% | 59.6% | 86.5% | -95.1% | -85.2% | -44.4% | 1.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.